RBC Capital Reiterates Outperform on Repligen, Maintains $191 Price Target
Portfolio Pulse from richadhand@benzinga.com
RBC Capital analyst Conor McNamara has reiterated an Outperform rating on Repligen (NASDAQ:RGEN) and maintained a price target of $191.
September 08, 2023 | 1:10 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated an Outperform rating on Repligen and maintained a price target of $191.
The reiteration of an Outperform rating by RBC Capital indicates a positive outlook for Repligen. The maintained price target of $191 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor confidence and potentially a rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100